Regentis Biomaterials Ltd. engages in the development of tissue repair solutions. It focuses on orthopedic treatments through its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue such as inflamed cartilage and bone tissue. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
10
Frequently Asked Questions
What is Market Cap of Regentis Biomaterials Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Regentis Biomaterials Ltd. market cap is $35.39M.
What is the 52-week high for Regentis Biomaterials Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Regentis Biomaterials Ltd. 52 week high is $8.00 as of December 15, 2025.
What is the 52-week low for Regentis Biomaterials Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Regentis Biomaterials Ltd. 52 week low is $6.96 as of December 15, 2025.
What is Regentis Biomaterials Ltd. stock price today?
Regentis Biomaterials Ltd. stock price today is $7.18.
What was Regentis Biomaterials Ltd. stock price yesterday?
Regentis Biomaterials Ltd. stock price yesterday was $7.14.
What is the PE ratio of Regentis Biomaterials Ltd.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Regentis Biomaterials Ltd.’s P/E ratio is -6.25.
What is the Price-to-Book ratio of Regentis Biomaterials Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Regentis Biomaterials Ltd. P/B ratio is -0.7984.
What is the 50-day moving average of Regentis Biomaterials Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Regentis Biomaterials Ltd. 50-day moving average is $7.41.
How many employess does Regentis Biomaterials Ltd. has?